Skip to content

Monocentric, randomized study to investigate the impact of telemonitoring on the frequency of hospital admissions due to exacerbations in patients with chronic obstructive lung disease under the observance of atmospheric conditions

Monocentric, randomized study to investigate the impact of telemonitoring on the frequency of hospital admissions due to exacerbations in patients with chronic obstructive lung disease under the observance of atmospheric conditions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00000705
Enrollment
220
Registered
2011-02-16
Start date
2011-03-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease (COPD), GOLD II- IV° J44.9 J44.8

Interventions

Group 1: Intervention Group- Telemonitoring, daily measurement of PEF, FEV1, FEV6, COPD Assessment Test (CAT) and self evaluation, weekly: 6-MWT during the first year. Addionally there are planned con

Sponsors

Charité Campus Charité Mitte CC12, Med. Klinik m. S. Infektiologie und Pneumologie Arbeitsbereich Pneumologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: COPD (GOLD: II-IV°) (FEV1 < 70% pred, FEV1/FVC < 70%), agreement of the patient, min. one exacerbation during the last year (antibiotics and/ or steroids and/or hospitalisation), min. 4 weeks of stable COPD befor inclusion into the study (no change of symptoms or medication)

Exclusion criteria

Exclusion criteria: o2- longterm-therapy (24h), cancer (expectation of life < 6 month), Asthma bronchiale, is not able to understand the studyprotocol and to use the devices because of a cognitive deficiency, diagnosis of left heart decompensation during the last year (chest X-ray or therapy with diuretics), lives not in or close to Berlin, high grade depression

Design outcomes

Primary

MeasureTime frame
Frequency of hospitalisations with a primary diagnosis of COPD exacerbation per year

Secondary

MeasureTime frame
Exacerbations: - Time to first hospitalisation with the primary diagnosis of a COPD exacerbation (time to first event) - Difference in the mean hospitalisation duration by admissions due to exacerbation - overall exacerbations per year - overall hospitalisations per year - Number of exacerbations per patient per year (worsening of symptoms and/or medical treatment) - Observance of changes in FEV1-/ FEV6/ PEF and progression during exacerbations during one year - Influence of heat/cold waves on the number and severety of exacerbations during one year Quality of life: - Number of patients with an improvement in quality of life during one year (improvement in St. George Respiratory Questionaire=SGRQ = 4 points, COPD Assessment Test=CAT improvement =4 points) - Influence of heat/cold waves on patients quality of life during one year (SGRQ/ CAT improvement in 3month/daily measurement Cost effectiveness: - cost for quality adjusted life years (QUALYs) during one year (EuroQol (EQ-5D), duration of hospital admission) Activity: - changes of BODE-Index (body-mass index (B), the degree of airflow obstruction (O) and dyspnea (D), and exercise capacity (E))per year - changes in 6-Minute Walk per year

Countries

Germany

Contacts

Public ContactNora Döhnert

Charité Campus Charité Mitte CC12, Med. Klinik für Infektiologie und Pneumologie Arbeitsbereich Pneumologie

nora.doehnert@charite.de030- 450 565058

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026